Mechanisms Underlying the Monocyte-mediated Antibody-dependent Killing of Plasmodium Falciparum Asexual Blood Stages

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1995 Aug 1

PMID 7629503

Citations 154

Authors

H Bouharoun-Tayoun

C Oeuvray

F Lunel

P Druilhe

Affiliations

Soon will be listed here.

Abstract

The relevance of the antibody-dependent cellular inhibition (ADCI) of Plasmodium falciparum to clinical protection has been previously established by in vitro studies of material obtained during passive transfer of protection by immunoglobulin G in humans. We here report further in vitro investigations aimed at elucidating the mechanisms underlying this ADCI effect. Results obtained so far suggest that (a) merozoite uptake by monocytes (MN) as well as by polymorphonuclear cells has little influence on the course of parasitemia; (b) the ADCI effect is mediated by a soluble factor released by MN; (c) this or these factors are able to block the division of surrounding intraerythrocytic parasites at the one nucleus stage; (d) the critical triggering antigen(s) targeted by effective Abs would appear to be associated with the surface of merozoites, as opposed to that of infected red blood cells; (e) the MN receptor for Abs effective in ADCI is apparently Fc gamma RII, and not RI; (f) MN function is up- and down-regulated by interferon-gamma and interleukin 4, respectively; and (g) of several potential mediators released by MN, only tumor necrosis factor (TNF) proved of relevance. The involvement of TNF in defense may explain the recently described increased frequency of the TNF-2 high-expression promoter in individuals living in endemic regions despite its compromising role in severe malaria.

Citing Articles

Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.

Rosenkranz M, Nkumama I, Ogwang R, Kraker S, Blickling M, Mwai K Life Sci Alliance. 2024; 7(8).

PMID: 38803222 PMC: 11106525. DOI: 10.26508/lsa.202301910.

Anti-Plasmodium vivax merozoite surface protein 3 ϒ (PvMSP3 ϒ) antibodies upon natural infection.

Kuamsab N, Putaporntip C, Kakino A, Kosuwin R, Songsaigath S, Tachibana H Sci Rep. 2024; 14(1):9595.

PMID: 38671033 PMC: 11053162. DOI: 10.1038/s41598-024-59153-w.

The intersection of host metabolism and immune responses to infection with kinetoplastid and apicomplexan parasites.

Ewald S, Nasuhidehnavi A, Feng T, Lesani M, McCall L Microbiol Mol Biol Rev. 2024; 88(1):e0016422.

PMID: 38299836 PMC: 10966954. DOI: 10.1128/mmbr.00164-22.

Human blood neutrophils generate ROS through FcγR-signaling to mediate protection against febrile P. falciparum malaria.

Ofori E, Garcia-Senosiain A, Naghizadeh M, Kana I, Dziegiel M, Adu B Commun Biol. 2023; 6(1):743.

PMID: 37463969 PMC: 10354059. DOI: 10.1038/s42003-023-05118-0.

Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites.

Lansink L, Skinner O, Engel J, Lee H, Soon M, Williams C mBio. 2023; 14(4):e0112923.

PMID: 37449844 PMC: 10470790. DOI: 10.1128/mbio.01129-23.

References

Tucker S, PIERRE R, Jordon R . Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods. 1977; 14(3-4):267-9. DOI: 10.1016/0022-1759(77)90137-5. View

Van Ostade X, Tavernier J, Fiers W . Structure-activity studies of human tumour necrosis factors. Protein Eng. 1994; 7(1):5-22. DOI: 10.1093/protein/7.1.5. View

Lambros C, Vanderberg J . Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979; 65(3):418-20. View

Mrema J, Langreth S, Jost R, Rieckmann K, HEIDRICH H . Plasmodium falciparum: isolation and purification of spontaneously released merozoites by nylon membrane sieves. Exp Parasitol. 1982; 54(3):285-95. DOI: 10.1016/0014-4894(82)90037-6. View

Haidaris C, Haynes J, Meltzer M, Allison A . Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum. Infect Immun. 1983; 42(1):385-93. PMC: 264569. DOI: 10.1128/iai.42.1.385-393.1983. View

Perussia B, Dayton E, Lazarus R, Fanning V, Trinchieri G . Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med. 1983; 158(4):1092-113. PMC: 2187379. DOI: 10.1084/jem.158.4.1092. View

Khusmith S, Druilhe P . Antibody-dependent ingestion of P. falciparum merozoites by human blood monocytes. Parasite Immunol. 1983; 5(4):357-68. DOI: 10.1111/j.1365-3024.1983.tb00751.x. View

Fandeur T, Dubois P, Gysin J, Dedet J, da Silva L . In vitro and in vivo studies on protective and inhibitory antibodies against Plasmodium falciparum in the Saimiri monkey. J Immunol. 1984; 132(1):432-7. View

Looney R, Abraham G, Anderson C . Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J Immunol. 1986; 136(5):1641-7. View

10.

Druilhe P, Khusmith S . Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status. Infect Immun. 1987; 55(4):888-91. PMC: 260434. DOI: 10.1128/iai.55.4.888-891.1987. View

11.

Descamps-Latscha B, Lunel-Fabiani F, Druilhe P . Generation of reactive oxygen species in whole blood from patients with acute falciparum malaria. Parasite Immunol. 1987; 9(2):275-9. DOI: 10.1111/j.1365-3024.1987.tb00507.x. View

12.

Oeuvray C, Bouharoun-Tayoun H, Gras-Masse H, Bottius E, Kaidoh T, Aikawa M . Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood. 1994; 84(5):1594-602. View

13.

McGuire W, Hill A, Allsopp C, Greenwood B, Kwiatkowski D . Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994; 371(6497):508-10. DOI: 10.1038/371508a0. View

14.

McColl D, Silva A, Foley M, Kun J, Favaloro J, Thompson J . Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites. Mol Biochem Parasitol. 1994; 68(1):53-67. DOI: 10.1016/0166-6851(94)00149-9. View

15.

Cohen S, McGregor I, Carrington S . Gamma-globulin and acquired immunity to human malaria. Nature. 1961; 192:733-7. DOI: 10.1038/192733a0. View

16.

Rzepczyk C, Lopez J, Anderson K, Alpers M . Investigation of the effect of monocytes with Papua New Guinea sera on Plasmodium falciparum in culture. Int J Parasitol. 1988; 18(3):401-6. DOI: 10.1016/0020-7519(88)90151-8. View

17.

Grau G, Taylor T, Molyneux M, Wirima J, Vassalli P, Hommel M . Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989; 320(24):1586-91. DOI: 10.1056/NEJM198906153202404. View

18.

Lunel F, Druilhe P . Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect Immun. 1989; 57(7):2043-9. PMC: 313839. DOI: 10.1128/iai.57.7.2043-2049.1989. View

19.

Fanger M, Shen L, Graziano R, Guyre P . Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today. 1989; 10(3):92-9. DOI: 10.1016/0167-5699(89)90234-X. View

20.

Ockenhouse C, Magowan C, Chulay J . Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro. J Clin Invest. 1989; 84(2):468-75. PMC: 548905. DOI: 10.1172/JCI114188. View